Palliative drainage methods for malignant ureteral obstruction: comparative analysis
https://doi.org/10.21886/2308-6424-2025-13-2-79-91
Abstract
The present review provides an in-depth analysis of palliative drainage modalities for the upper urinary tract (UUT) in patients diagnosed with cancer-associated obstructive uropathy. Although nephrostomy-based drainage is widely acknowledged as a valid approach, prolonged utilization of external urinary drainage systems is associated with specific complications and exerts a considerable impact on patients’ quality of life. Consequently, the quest for an optimal variant of prolonged internal urinary tract drainage in this patient population remains an ongoing endeavor. The primary parameters constraining the efficacy of conventional ureteral stenting include stent patency compromise due to tumor compression and stent lumen occlusion resulting from encrustation. Furthermore, the prevalence of stent-related symptomatology in most patients represents a significant clinical concern. This review synthesizes the findings of studies that both elucidate the factors limiting the utility of ureteral stenting in this patient cohort and propose strategies to overcome these limitations through targeted interventions addressing the physical, chemical, and biological determinants of internal ureteral drainage failure.
About the Authors
K. I. Glinin
Pirogov Russian National Research Medical University ; Buyanov City Clinical Hospital
Russian Federation
Competing Interests:
Russian Federation
Kirill I. Glinin
Moscow
Competing Interests:
The authors declare no conflicts of interest
I. E. Mamaev
Pirogov Russian National Research Medical University ; Buyanov City Clinical Hospital
Russian Federation
Competing Interests:
Russian Federation
Ibragim E. Mamaev — Cand.Sc.(Med)
Moscow
Competing Interests:
The authors declare no conflicts of interest
S. V. Kotov
Pirogov Russian National Research Medical University ; Pirogov City Clinical Hospital No. 1 ; “Kommunarka” Moscow Multidisciplinary Clinical Centre
Russian Federation
Competing Interests:
Russian Federation
Sergey V. Kotov — Dr.Sc.(Med), Full Prof.
Moscow
Competing Interests:
The authors declare no conflicts of interest
References
1. Chissov VI, Dar’jalova SL. Onkologija. Moscow: GJeOTAR-Media; 2007. (In Russian). ISBN 978-5-9704-0454-6
2. Orlova RV. Lekarstvennoe lechenie opuholej zheludochno-kishechnogo trakta. Prakticheskaja onkologija. 2005;6(1):33-42. (In Russian). eLIBRARY ID: 19394699; EDN: QIKTVP
3. Komyakov B.K., Guliyev B.G. Internal drainage of the upper urinary tract in ureteral tumor obstructions: a review of literature. Cancer Urology. 2010;6(2):78-83. (In Russian). DOI: 10.17650/1726-9776-2010-6-2-78-83
4. Smirnova SV. Vybor metoda lechenija striktur mochetochnika u bol’nyh zlokachestvennymi opuholjami organov malogo taza [dissertation]. Moscow; 2009. (In Russian). Accessed February 03, 2025. URL: http://www.dslib.net/onkologia/vybor-metoda-lechenija-strikturmochetochnika-u-bolnyh-zlokachestvennymi-opuholjami.html
5. Zadra JA, Jewett MA, Keresteci AG, Rankin JT, St Louis E, Grey RR, Pereira JJ. Nonoperative urinary diversion for malignant ureteral obstruction. Cancer. 1987;60(6):1353-1357. DOI: 10.1002/1097-0142(19870915)60:6<1353::aid-cncr2820600632>3.0.co;2-5
6. Ganatra AM, Loughlin KR. The management of malignant ureteral obstruction treated with ureteral stents. J Urol. 2005;174(6):2125-2128. DOI: 10.1097/01.ju.0000181807.56114.b7
7. Rose PG, Ali S, Whitney CW, Lanciano R, Stehman FB. Impact of hydronephrosis on outcome of stage IIIB cervical cancer patients with disease limited to the pelvis, treated with radiation and concurrent chemotherapy: a Gynecologic Oncology Group study. Gynecol Oncol. 2010;117(2):270-275. DOI: 10.1016/j.ygyno.2010.01.045
8. Izumi K, Mizokami A, Maeda Y, Koh E, Namiki M. Current outcome of patients with ureteral stents for the management of malignant ureteral obstruction. J Urol. 2011;185(2):556-561. DOI: 10.1016/j.juro.2010.09.102
9. Yossepowitch O, Lifshitz DA, Dekel Y, Gross M, Keidar DM, Neuman M, Livne PM, Baniel J. Predicting the success of retrograde stenting for managing ureteral obstruction. J Urol. 2001;166(5):1746-1749. PMID: 11586215
10. Kogan MI, Shkodkin SV, Ljubushkin AV, Miroshnichenko OV. Directions and perspectives of the urological stent development (literature review). Experimental and clinical urology. 2014;4:64-71. (In Russian). eLIBRARY ID: 23702176; EDN: TYRNXN
11. Kanou T, Fujiyama C, Nishimura K, Tokuda Y, Uozumi J, Masaki Z. Management of extrinsic malignant ureteral obstruction with urinary diversion. Int J Urol. 2007;14(8):689-692. DOI: 10.1111/j.1442-2042.2007.01747.x
12. Alma E, Ercil H, Vuruskan E, Altunkol A, Unal U, Gurlen G, Goren V, Gurbuz ZG. Long-term follow-up results and complications in cancer patients with persistent nephrostomy due to malignant ureteral obstruction. Support Care Cancer. 2020;28(11):5581-5588. DOI: 10.1007/s00520-020-05662-z
13. McDevitt JL, Acosta-Torres S, Zhang N, Hu T, Odu A, Wang J, Xi Y, Lamus D, Miller DS, Pillai AK. Long-Term Percutaneous Nephrostomy Management of Malignant Urinary Obstruction: Estimation of Optimal Exchange Frequency and Estimation of the Financial Impact of Patient Compliance. J Vasc Interv Radiol. 2017;28(7):1036-1042.e8. DOI: 10.1016/j.jvir.2017.02.031
14. Ivanov V.Yu., Malhasyan V.A., Semenyakin I.V., Gadzhiev N.K., Tedeev A.V., Pushkar’ D.Yu. Choice of the optimal method of upper urinary tract drainage in patients with acute obstructive pyelonephritis. Experimental and clinical urology. 2017;(1):58-66. (In Russian). eLIBRARY ID: 29899561; EDN: ZEHPFD
15. Lopatkina N.A., ed. Urologija. Uchebnik dlja VUZov. 5-e izd., pererab. i dop. Moscow: GJeOTAR-MED; 2004. (In Russian).
16. Novikov A.B., Sergeev V.P., Ergakov D.V., Galliamov E.A., Martov A.G. Stenting of the upper urinary tract: from bottom, from top, from side... Research and Practical Medicine Journal. 2020;7(4):105-117. (In Russian). DOI: 10.17709/2409-2231-2020-7-4-9
17. Tsukanov A.Yu., Akhmetov D.S., Novikov A.A., Negrov D.A., Putintseva A.R. Prevention of encrustation and biofilm formation ureteral stent surface. Part 1. Experimental and Clinical Urology. 2020;(3):176-181. (In Russian). DOI: 10.29188/2222-8543-2020-12-3-176-181
18. Zolotuhin O.V., Madykin Y.Y., Fedorov A.A. Evolution of upper urinary tract drainage method. Journal of Experimental and Clinical Surgery. 2019;12(3):199-202. (In Russian). DOI: 10.18499/2070-478X-2019-12-3-199-202
19. Matsuura H, Arase S, Hori Y. Ureteral stents for malignant extrinsic ureteral obstruction: outcomes and factors predicting stent failure. Int J Clin Oncol. 2019;24(3):306-312. DOI: 10.1007/s10147-018-1348-6
20. Chow PM, Chiang IN, Chen CY, Huang KH, Hsu JS, Wang SM, Lee YJ, Yu HJ, Pu YS, Huang CY. Malignant Ureteral Obstruction: Functional Duration of Metallic versus Polymeric Ureteral Stents. PLoS One. 2015;10(8):e0135566. DOI: 10.1371/journal.pone.0135566
21. Modi AP, Ritch CR, Arend D, Walsh RM, Ordonez M, Landman J, Gupta M, Knudsen BE. Multicenter experience with metallic ureteral stents for malignant and chronic benign ureteral obstruction. J Endourol. 2010;24(7):1189-1193. DOI: 10.1089/end.2010.0121
22. Goldsmith ZG, Wang AJ, Bañez LL, Lipkin ME, Ferrandino MN, Preminger GM, Inman BA. Outcomes of metallic stents for malignant ureteral obstruction. J Urol. 2012;188(3):851-855. DOI: 10.1016/j.juro.2012.04.113
23. Papadopoulos GI, Middela S, Srirangam SJ, Szczesniak CA, Rao PN. Use of Memokath 051 metallic stent in the management of ureteral strictures: a single-center experience. Urol Int. 2010;84(3):286-291. DOI: 10.1159/000288230
24. Cormio L, Talja M, Koivusalo A, Mäkisalo H, Wolff H, Ruutu M. Biocompatibility of various indwelling double-J stents. J Urol. 1995;153(2):494- 496. DOI: 10.1097/00005392-199502000-00069
25. Hübner WA, Plas EG, Stoller ML. The double-J ureteral stent: in vivo and in vitro flow studies. J Urol. 1992;148(2 Pt 1):278-280. DOI: 10.1016/s0022-5347(17)36572-2
26. Elsamra SE, Leavitt DA, Motato HA, Friedlander JI, Siev M, Keheila M, Hoenig DM, Smith AD, Okeke Z. Stenting for malignant ureteral obstruction: Tandem, metal or metal-mesh stents. Int J Urol. 2015;22(7):629- 636. DOI: 10.1111/iju.12795
27. Liu JS, Hrebinko RL. The use of 2 ipsilateral ureteral stents for relief of ureteral obstruction from extrinsic compression. J Urol. 1998;159(1):179- 181. DOI: 10.1016/s0022-5347(01)64050-3
28. Hafron J, Ost MC, Tan BJ, Fogarty JD, Hoenig DM, Lee BR, Smith AD. Novel dual-lumen ureteral stents provide better ureteral flow than single ureteral stent in ex vivo porcine kidney model of extrinsic ureteral obstruction. Urology. 2006;68(4):911-915. DOI: 10.1016/j.urology.2006.05.025
29. Elsamra SE, Motato H, Moreira DM, Waingankar N, Friedlander JI, Weiss G, Smith AD, Okeke Z. Tandem ureteral stents for the decompression of malignant and benign obstructive uropathy. J Endourol. 2013;27(10):1297-1302. DOI: 10.1089/end.2013.0281
30. Liu KL, Lee BC, Ye JD, Chang YH, Chang CC, Huang KH, Lee YJ, Chang YC. Comparison of single and tandem ureteral stenting for malignant ureteral obstruction: a prospective study of 104 patients. Eur Radiol. 2019;29(2):628-635. DOI: 10.1007/s00330-018-5560-6
31. Ku JH, Lee SW, Jeon HG, Kim HH, Oh SJ. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences? Urology. 2004;64(5):895-899. DOI: 10.1016/j.urology.2004.06.029
32. Tan S, Tao Z, Bian X, Zhao Y, Wang N, Chen X, Wu B. Ureteral stent placement and percutaneous nephrostomy in the management of hydronephrosis secondary to cervical cancer. Eur J Obstet Gynecol Reprod Biol. 2019;241:99-103. DOI: 10.1016/j.ejogrb.2019.08.020
33. Stickler DJ, Evans A, Morris N, Hughes G. Strategies for the control of catheter encrustation. Int J Antimicrob Agents. 2002;19(6):499-506. DOI: 10.1016/s0924-8579(02)00091-2
34. Dakkak Y, Janane A, Ould‐Ismail T, Ghadouane M, Ameur A, Abbar M. Management of encrusted ureteral stents. African Journal of Urology. 2012;18(3):131-134. DOI: 10.1016/j.afju.2012.08.013
35. Wilson M, Devine D. Medical Implications of Biofilms. Cambridge University Press; 2003. DOI: 10.1017/CBO9780511546297
36. Ho CC, Khandasamy Y, Singam P, Hong Goh E, Zainuddin ZM. Encrusted and incarcerated urinary bladder catheter: what are the options? Libyan J Med. 2010;5. DOI: 10.3402/ljm.v5i0.5686
37. Broomfield RJ, Morgan SD, Khan A, Stickler DJ. Crystalline bacterial biofilm formation on urinary catheters by urease-producing urinary tract pathogens: a simple method of control. J Med Microbiol. 2009;58(Pt 10):1367-1375. DOI: 10.1099/jmm.0.012419-0
38. Nickel JC, Costerton JW. Bacterial biofilms and catheters: A key to understanding bacterial strategies in catheter‐associated urinary tract infection. Can J Infect Dis.1992;3:261-267. DOI: 10.1155/1992/517456
39. Trautner BW, Darouiche RO. Role of biofilm in catheter-associated urinary tract infection. Am J Infect Control. 2004;32(3):177-183. DOI: 10.1016/j.ajic.2003.08.005
40. Watnick P, Kolter R. Biofilm, city of microbes. J Bacteriol. 2000;182(10):2675-2679. DOI: 10.1128/JB.182.10.2675-2679.2000
41. Maltsev S.V., Mansurovа G.S. What is biofilm? Prakticheskaja medicina. 2011;5(53):7-10. (In Russian). eLIBRARY ID: 17049949; EDN: OJCSER
42. El-Azizi M, Rao S, Kanchanapoom T, Khardori N. In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci. Ann Clin Microbiol Antimicrob. 2005;4:2. DOI: 10.1186/1476-0711-4-2
43. Stickler DJ, Lear JC, Morris NS, Macleod SM, Downer A, Cadd DH, Feast WJ. Observations on the adherence of Proteus mirabilis onto polymer surfaces. J Appl Microbiol. 2006;100(5):1028-1033. DOI: 10.1111/j.1365-2672.2006.02840.x
44. Trinchieri A. Calcolosi urinaria e infezione [Urinary calculi and infection]. Urologia. 2014;81(2):93-98. (In Italian). DOI: 10.5301/uro.5000073
45. Macleod SM, Stickler DJ. Species interactions in mixed-community crystalline biofilms on urinary catheters. J Med Microbiol. 2007;56(Pt 11):1549-1557. DOI: 10.1099/jmm.0.47395-0
46. Zunino P, Sosa V, Allen AG, Preston A, Schlapp G, Maskell DJ. Proteus mirabilis fimbriae (PMF) are important for both bladder and kidney colonization in mice. Microbiology (Reading). 2003;149(Pt 11):3231- 3237. DOI: 10.1099/mic.0.26534-0
47. Waters SL, Heaton K, Siggers JH, Bayston R, Bishop M, Cummings LJ, Grant DM, Oliver JM, Wattis JA. Ureteric stents: investigating flow and encrustation. Proc Inst Mech Eng H. 2008;222(4):551-561. DOI: 10.1243/09544119JEIM317
48. Grases F, Söhnel O, Costa-Bauzá A, Ramis M, Wang Z. Study on concretions developed around urinary catheters and mechanisms of renal calculi development. Nephron. 2001;88(4):320-328. DOI: 10.1159/000046015
49. Grases F, Sanchis P, Isern B, Perelló J, Costa-Bauzá A. Uric acid as inducer of calcium oxalate crystal development. Scand J Urol Nephrol. 2007;41(1):26-31. DOI: 10.1080/00365590600831571
50. Wagner CA, Mohebbi N. Urinary pH and stone formation. J Nephrol. 2010;23 Suppl 16:S165-9. PMID: 21170875
51. Lo J, Lange D, Chew BH. Ureteral Stents and Foley Catheters-Associated Urinary Tract Infections: The Role of Coatings and Materials in Infection Prevention. Antibiotics (Basel). 2014;3(1):87-97. DOI: 10.3390/antibiotics3010087
52. Desai DG, Liao KS, Cevallos ME, Trautner BW. Silver or nitrofurazone impregnation of urinary catheters has a minimal effect on uropathogen adherence. J Urol. 2010;184(6):2565-2571. DOI: 10.1016/j.juro.2010.07.036
53. Noimark S, Dunnill CW, Wilson M, Parkin IP. The role of surfaces in catheter-associated infections. Chem Soc Rev. 2009;38(12):3435-3448. DOI: 10.1039/b908260c
54. Choong SK, Wood S, Whitfield HN. A model to quantify encrustation on ureteric stents, urethral catheters and polymers intended for urological use. BJU Int. 2000;86(4):414-421. DOI: 10.1046/j.1464-410x.2000.00861.x
55. Hildebrandt P, Sayyad M, Rzany A, Schaldach M, Seiter H. Prevention of surface encrustation of urological implants by coating with inhibitors. Biomaterials. 2001;22(5):503-507. DOI: 10.1016/s0142-9612(00)00217-9
56. Tofail S, ed. Biological Interactions with Surface Charge in Biomaterials. 2011. DOI: 10.1039/9781849733366
57. Riley DK, Classen DC, Stevens LE, Burke JP. A large randomized clinical trial of a silver-impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. Am J Med. 1995;98(4):349-356. DOI: 10.1016/S0002-9343(99)80313-1
58. Stickler DJ, Feneley RC. The encrustation and blockage of long-term indwelling bladder catheters: a way forward in prevention and control. Spinal Cord. 2010;48(11):784-790. DOI: 10.1038/sc.2010.32
59. Lange D, Elwood CN, Chew BH. Biomaterials in Urology - Beyond Drug Eluting and Degradable - A Rational Approach to Ureteral Stent Design. In: Pignatello R, ed. Biomaterials - Physics and Chemistry. 2011. DOI: 10.5772/24209
60. Penniston KL, Nakada SY, Holmes RP, Assimos DG. Quantitative assessment of citric acid in lemon juice, lime juice, and commercially-available fruit juice products. J Endourol. 2008;22(3):567-570. DOI: 10.1089/end.2007.0304
Review
For citations:
Glinin K.I., Mamaev I.E., Kotov S.V. Palliative drainage methods for malignant ureteral obstruction: comparative analysis. Urology Herald. 2025;13(2):79-91. (In Russ.) https://doi.org/10.21886/2308-6424-2025-13-2-79-91
Views:
162
Email this article 
